CS logo
small CS logo
Department of Hematology, Rikshospitalet University Hospital

Oslo, Norway

About Department of Hematology, Rikshospitalet University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of Hematology, Rikshospitalet University Hospital


During the past decade, Department of Hematology, Rikshospitalet University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Rikshospitalet University Hospital" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

Clinical Trials Conditions at Department of Hematology, Rikshospitalet University Hospital


According to Clinical.Site data, the most researched conditions in "Department of Hematology, Rikshospitalet University Hospital" are "Leukemia, Acute Lymphoblastic" (2 trials), "MDS" (2 trials), "AML" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials) and "MRD" (1 trials). Many other conditions were trialed in "Department of Hematology, Rikshospitalet University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Department of Hematology, Rikshospitalet University Hospital


Most popular intervention types in "Department of Hematology, Rikshospitalet University Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Azacitidine" (1 trials), "Blinatumomab" (1 trials), "Erythropoetin" (1 trials) and "Imatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of Hematology, Rikshospitalet University Hospital


The vast majority of trials in "Department of Hematology, Rikshospitalet University Hospital" are 5 trials for "All" genders.

Clinical Trials Status at Department of Hematology, Rikshospitalet University Hospital


Currently, there are NaN active trials in "Department of Hematology, Rikshospitalet University Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Hematology, Rikshospitalet University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Hematology, Rikshospitalet University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".